Summit Therapeutics (SMMT) News Today $18.98 +0.67 (+3.66%) (As of 11/18/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Summit Therapeutics' (SMMT) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $44.00 price objective on shares of Summit Therapeutics in a report on Monday.November 18 at 8:11 AM | marketbeat.comMarketBeat Week in Review – 11/4 - 11/8 (SMMT)Markets rallied strongly this week on clarity about the election and an expected rate cut, but next week's inflation readings will determine if momentum lastsNovember 9, 2024 | marketbeat.com2 Hot Biopharma Stocks to Buy and Hold for 5 YearsNovember 8, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Now Covered by JMP SecuritiesNovember 8, 2024 | americanbankingnews.comWhy Summit Therapeutics Stock Was a Winner TodayNovember 4, 2024 | fool.comSummit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And OpdivoNovember 4, 2024 | benzinga.comSummit Therapeutics: Is Their Lung Cancer Drug a Game Changer?Summit Therapeutics Inc. aims to advance Ivonescimab, a potential breakthrough for NSCLC. The FDA's Fast Track designation boosts its U.S. clinical pathway.November 4, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at JMP SecuritiesJMP Securities began coverage on shares of Summit Therapeutics in a report on Monday. They set a "market outperform" rating and a $32.00 target price for the company.November 4, 2024 | marketbeat.com3 Magnificent Stocks Under $100 to Buy in NovemberNovember 3, 2024 | fool.comabrdn plc Takes $24.89 Million Position in Summit Therapeutics Inc. (NASDAQ:SMMT)abrdn plc bought a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,136,286 shares of the company's stock, valued at approNovember 1, 2024 | marketbeat.comDecoding Summit Therapeutics Inc (SMMT): A Strategic SWOT InsightNovember 1, 2024 | uk.finance.yahoo.comSummit Therapeutics price target lowered to $44 from $45 at H.C. WainwrightNovember 1, 2024 | markets.businessinsider.comSummit Therapeutics Inc. (NASDAQ:SMMT) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | insidermonkey.comHC Wainwright Has Lowered Expectations for Summit Therapeutics (NASDAQ:SMMT) Stock PriceHC Wainwright lowered their price objective on Summit Therapeutics from $45.00 to $44.00 and set a "buy" rating on the stock in a research report on Thursday.October 31, 2024 | marketbeat.com3 Stocks That Have Generated 1,000% Returns in Just 2 YearsOctober 31, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Shares Down 10.4% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Shares Down 10.4% - Time to Sell?October 30, 2024 | marketbeat.comChina Universal Asset Management Co. Ltd. Has $3.05 Million Stock Position in Summit Therapeutics Inc. (NASDAQ:SMMT)China Universal Asset Management Co. Ltd. boosted its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 69.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 139,352 shares of the coOctober 29, 2024 | marketbeat.comIs Summit Therapeutics a Millionaire Maker?October 27, 2024 | fool.comSummit Therapeutics Inc. (SMMT): An Unstoppable Stock That Could Make You RicherOctober 27, 2024 | finance.yahoo.comPublic company CEOs pay $33M for Brickell penthouse (Photos)October 24, 2024 | bizjournals.comSummit Therapeutics (SMMT) Scheduled to Post Quarterly Earnings on WednesdaySummit Therapeutics (NASDAQ:SMMT) will be releasing earnings before the market opens on Wednesday, October 30, Zacks reports.October 24, 2024 | marketbeat.comBillionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock RallyOctober 24, 2024 | msn.comUp Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?October 24, 2024 | fool.comExchange Traded Concepts LLC Sells 39,252 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Exchange Traded Concepts LLC reduced its stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 85.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,499 shOctober 23, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading 0.4% Higher - Still a Buy?Summit Therapeutics (NASDAQ:SMMT) Trading Up 0.4% - Should You Buy?October 22, 2024 | marketbeat.comBillionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?October 22, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Trading Up 0.8% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 0.8% - Here's What HappenedOctober 21, 2024 | marketbeat.comSummit Therapeutics Inc Ordinary SharesOctober 19, 2024 | morningstar.comSummit Therapeutics (NASDAQ:SMMT) Trading Down 5% - Should You Sell?Summit Therapeutics (NASDAQ:SMMT) Trading Down 5% - Time to Sell?October 17, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 5.4% - Still a Buy?Summit Therapeutics (NASDAQ:SMMT) Shares Up 5.4% - Here's WhyOctober 16, 2024 | marketbeat.comGriffin Asset Management Inc. Buys New Shares in Summit Therapeutics Inc. (NASDAQ:SMMT)Griffin Asset Management Inc. bought a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 67,760 shares of the company's stock, valued at approximately $1,484,000.October 16, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 3.8% - Should You Buy?Summit Therapeutics (NASDAQ:SMMT) Shares Up 3.8% - Here's WhyOctober 15, 2024 | marketbeat.comUp 700% This Year, Is It Too Late to Invest in This Stock?October 15, 2024 | fool.comAQR Capital Management LLC Purchases New Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)AQR Capital Management LLC purchased a new position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 62,114 shares of the company's stock, valued at appOctober 15, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading 0.3% Higher - Time to Buy?Summit Therapeutics (NASDAQ:SMMT) Shares Up 0.3% - Still a Buy?October 14, 2024 | marketbeat.com32,756 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Acquired by SG Americas Securities LLCSG Americas Securities LLC bought a new position in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm bought 32,756 shares of the company's stock, valued at approximately $717,000. A number of other insOctober 14, 2024 | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Short Interest UpdateSummit Therapeutics Inc. (NASDAQ:SMMT - Get Free Report) saw a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 16,340,000 shares, a decline of 21.2% from the September 15th total of 20,730,000 shares. Based on an average daily trading volume, of 4,950,000 shares, the days-to-cover ratio is currently 3.3 days.October 13, 2024 | marketbeat.comBetter Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit TherapeuticsOctober 13, 2024 | fool.com3 Things You Need to Know If You Buy Summit Therapeutics Stock TodayOctober 12, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 2% - Time to Buy?Summit Therapeutics (NASDAQ:SMMT) Trading 2% Higher - What's Next?October 11, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Raises Stake in Summit Therapeutics Inc. (NASDAQ:SMMT)The Manufacturers Life Insurance Company increased its stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 167.2% during the second quarter, according to its most recent filing with the SEC. The fund owned 206,057 shares of the company's stock after buying an additional 128,934 sharesOctober 11, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading Down 1.2% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 1.2% - Should You Sell?October 10, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 1% - Time to Sell?Summit Therapeutics (NASDAQ:SMMT) Shares Down 1% - Here's WhyOctober 9, 2024 | marketbeat.comSquarepoint Ops LLC Buys 56,614 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Squarepoint Ops LLC lifted its stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 192.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 86,064 shares of the company's stock after purchasing an additOctober 9, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading Down 1.5% - Here's What HappenedSummit Therapeutics (NASDAQ:SMMT) Shares Down 1.5% - Here's What HappenedOctober 7, 2024 | marketbeat.com2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street AnalystsOctober 7, 2024 | fool.comMillennium Management LLC Takes Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Millennium Management LLC acquired a new stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,942,858 shares of the company's stock, valued at approximately $15,154,000.October 7, 2024 | marketbeat.comSummit Therapeutics Inc. (SMMT): Hedge Funds Are Bullish On This NASDAQ Stock Right NowOctober 6, 2024 | msn.comIs Summit Therapeutics a Millionaire Maker?October 5, 2024 | fool.comS&P 500 Futures Rise in Premarket Trading; Summit Therapeutics, Axalta Coating Systems LeadOctober 4, 2024 | marketwatch.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address A huge crack is forming in the US economy (Ad)Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.” Learn how to protect yourself too, click here. SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.620.57▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼34▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today BioNTech News Today Teva Pharmaceutical Industries News Today Moderna News Today BeiGene News Today Genmab A/S News Today Viatris News Today Vaxcyte News Today Sarepta Therapeutics News Today Catalent News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMMT Stock Alerts